Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Maeve Lowery

Has grant

Professor of Translational Cancer Medicine

Trinity College Dublin

Ireland

Research Interests

Explore related searches

Professors in Ireland

Recent Grants

Grant: Close

Identification of coding and novel regulatory mutations in DNA Damage Response (DDR) pathway genes as personalised targets for the treatment of patients with pancreatic cancer.

Open Date: 2019-01-01

Close Date: 2022-01-01

Grant: Close

PancREatic Cancer OrganoiDs rEsearch Network

Open Date: 2019-01-01

Close Date: 2022-01-01

Grant: Close

Whole genome and transcriptome sequencing of extreme phenotypes in gastrointestinal cancer

Open Date: 2019-01-01

Close Date: 2022-01-01

Grant: Close

Imaging drug uptake and distribution in chemoradiation therapy of pancreatic cancer

Open Date: 2016-07-01

Close Date: 2020-06-30

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Julien Edeline

PU-PH - Full Professor

Université de Rennes 1 Faculté de Médecine

FRANCE

View details

Tomasz Olesinski

Head of Surgical Department

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Rosalyn Juergens

CANADA

View details

Grainne M. O'Kane

University College Dublin

IRELAND

View details

Naomi Walsh

Associate Professor

Dublin City University

IRELAND

View details

Walter Kolch

Dublin City University

IRELAND

View details

Sara Lonardi

Head of Dept

Istituto Oncologico Veneto

ITALY

View details

Andrea Casadei-Gardini

Ospedale San Raffaele

ITALY

View details

Sam Lubner

Associate Professor of Medicine

University of Wisconsin-Madison Carbone Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Maeve Lowery

Research Interests

Explore related searches

Recent Grants

Articles (19)

New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe

Pembrolizumab with trastuzumab and chemotherapy for HER2-positive advanced gastric cancer: health-related quality-of-life analysis from the randomized KEYNOTE-811 trial

Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170].

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

First-line pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: Health-related quality of life from the randomized phase III KEYNOTE-859 trial.

Mechanisms of Resistance to PARPi in Pancreatic Ductal Adenocarcinoma.

International Fibrolamellar Cancer Registry: Opportunities and Challenges.

Overview of Molecular Diagnostics in Irish Clinical Oncology.

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer.

Targeting MET amplification in Gastro-oesophageal (GO) malignancies and overcoming MET inhibitor resistance: challenges and opportunities.

Consensus statement on the surveillance of patients with gastrointestinal malignancies.

Patient knowledge, personal experience, and impact of the first wave of the COVD-19 pandemic in an Irish oncology cohort.

DNA Damage Repair Deficiency in Pancreatic Ductal Adenocarcinoma: Preclinical Models and Clinical Perspectives.

FLOT-regimen Chemotherapy and Transthoracic en bloc Resection for Esophageal and Junctional Adenocarcinoma.

Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial.

Advances in the curative management of oesophageal cancer.

Ivosidenib for the treatment of isocitrate dehydrogenase-1 mutant cholangiocarcinoma.

Early-Onset Pancreas Cancer: Clinical Descriptors, Genomics, and Outcomes.

Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma.

Collaborators (9)

Julien Edeline

Tomasz Olesinski

Rosalyn Juergens

Grainne M. O'Kane

Naomi Walsh

Walter Kolch

Sara Lonardi

Andrea Casadei-Gardini

Sam Lubner

Make your next move.